PGNY Progyny

Progyny Strengthens Board of Directors with Appointment of Healthcare Leader and Advocate

Progyny Strengthens Board of Directors with Appointment of Healthcare Leader and Advocate

NEW YORK, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced the appointment of a new member to its board of directors, effective August 30, 2022. Joining the board is Lloyd Dean, Chief Executive Emeritus and Founding Executive of CommonSpirit Health.

“I am excited to welcome Lloyd to the Board and believe the value he brings from his experience on expanding access to healthcare will be an asset as we explore how we can further our reach when it comes to infertility and family building,” said Pete Anevski, Chief Executive Officer of Progyny. “He brings complementary skills and experiences to the company that will help us continue on our path of high growth and industry leadership.”

Mr. Dean will serve on the Nominating and Corporate Governance Committee. Following this appointment, the Progyny Board now consists of ten directors.

Mr. Dean brings to Progyny over 40 years of practice in improving health and expanding access to healthcare for all. As a Founding Executive of CommonSpirit Health, one of the nation’s largest not-for-profit healthcare companies, Mr. Dean delivered on his vision of a healthcare system that uses innovative partnerships, modern technology, and human kindness so that more Americans can live in a healthier future. He was instrumental in creating CommonSpirit Health in February 2019, when Dignity Health and Catholic Health Initiatives combined to form one of the nation’s leading providers of Medicaid and other healthcare services. Previously, he was CEO from 2019 to 2022, and prior to that, Mr. Dean was President and CEO of Dignity Health from 2012 to 2019, which grew under his leadership from a holding company into a dynamic healthcare enterprise.

As an advocate for healthcare, Mr. Dean has served on many federal and state advisory panels and participated in regional and national charity and advocacy organizations. Since August 2015, Mr. Dean has also served on the board of directors of McDonald's Corporation. Additionally, Mr. Dean currently serves on the board of directors of Cal Poly State University Foundation, Carnegie Hall, CommonSpirit Health Foundation, Golden Arrow Merger Corp, and Guidehouse. Mr. Dean holds a Bachelor of Science in Sociology and a Master's in Education from Western Michigan University, an honorary Doctorate of Humane Letters from the University of San Francisco, and an honorary Doctor of Science degree from Morehouse School of Medicine, California State University and California Polytechnic State University.

“I am honored to join a company that continues to deliver exceptional clinical outcomes, reduce healthcare spending for employers, and deliver an unparallel patient experience while expanding its footprint into other markets and industries,” said Mr. Dean. “It’s clear Progyny is the brand of choice for large employers when it comes to family building benefits, and I look forward to supporting its growth and value for all of its stakeholders.”

For more information visit

About Progyny

Progyny (Nasdaq: PGNY) is a leading fertility benefits management company. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive solution can simultaneously benefit employers, patients, and physicians.

Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.

Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit

For Further Information, Please Contact:

Investors:

James Hart



Media:

Selena Yang



EN
06/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Progyny

 PRESS RELEASE

Progyny, Inc. Announces Second Quarter 2025 Results

Progyny, Inc. Announces Second Quarter 2025 Results Reports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance to Reflect Continued Increase in Pacing of Member Engagement NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, today announced its financial results for the three-month period ended June 30, 2025 (“the second quarter of 202...

 PRESS RELEASE

New Progyny Study Reveals Gap Between Perceptions and Realities in Wom...

New Progyny Study Reveals Gap Between Perceptions and Realities in Women’s Health Benefits Coverage Increased awareness of expanded women’s health and family building solutions has led to a growing disconnect between most wanted employee benefits and employer offerings NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced the results of their new national research conducted in partnership with Dynata, the world’s largest first-party data company for insights, activation, and measurement...

 PRESS RELEASE

Progyny Partners with ŌURA to Empower Women and Their Care Teams with ...

Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced a new partnership with , maker of the world’s leading smart ring, further empowering women to better understand and take action on their health through comprehensive data and personalized insights. By incorporating wearable data and insights from ŌURA into the care team decision-support process—from p...

 PRESS RELEASE

Progyny, Inc. Provides Business Update and Announces Details for Its S...

Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report Operational and Financial Flexibility Enhanced Through New Credit FacilitySecond Quarter Results Anticipated to be Slightly Above Previously Provided Financial Guidance NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a global leader in women's health and family building solutions, today announced that it has entered into a revolving credit facility (the “revolver” or the “facility”) which makes available to the Company up to $200 m...

 PRESS RELEASE

Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Ac...

Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s Health With nearly one third of women impacted by pelvic floor disorders, expanded care access and education from Progyny will help eliminate the silent suffering NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that it is adding to its comprehensive offering of women’s health and family building solutions. With the expansion of its network of specialty trained women’s health providers, and the addition of ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch